• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis.

作者信息

Saeed Aamir, Ahmad Basharat, Majaz Sidra, Nouroz Faisal, Ahmad Ashfaq, Xie Yingqiu

机构信息

Department of Bioinformatics, Hazara University, Mansehra 21300, Pakistan.

Department of Bioinformatics, Hazara University, Mansehra 21300, Pakistan.

出版信息

J Infect. 2022 Jun;84(6):e133-e136. doi: 10.1016/j.jinf.2022.02.012. Epub 2022 Feb 17.

DOI:10.1016/j.jinf.2022.02.012
PMID:35183608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851874/
Abstract
摘要

相似文献

1
Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis.通过主要蛋白酶3CL Mpro的强效抑制剂靶向奥密克戎和其他已报道的SARS-CoV-2谱系：分子模拟分析
J Infect. 2022 Jun;84(6):e133-e136. doi: 10.1016/j.jinf.2022.02.012. Epub 2022 Feb 17.
2
Finding potent inhibitors for COVID-19 main protease (M): an approach using SARS-CoV-3CL protease inhibitors for combating CORONA.寻找 COVID-19 主蛋白酶（M）的有效抑制剂：利用 SARS-CoV-3CL 蛋白酶抑制剂对抗 CORONA。
J Biomol Struct Dyn. 2022 Mar;40(4):1534-1545. doi: 10.1080/07391102.2020.1829501. Epub 2020 Oct 8.
3
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an docking and molecular dynamics simulation study.评估绿茶多酚作为新型冠状病毒（SARS-CoV-2）主蛋白酶（Mpro）抑制剂的研究 - 对接和分子动力学模拟。
J Biomol Struct Dyn. 2021 Aug;39(12):4362-4374. doi: 10.1080/07391102.2020.1779818. Epub 2020 Jun 22.
4
Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19.基于马来酰亚胺类似物的高效 SARS-CoV-2 主蛋白酶抑制剂的开发用于 COVID-19 的潜在治疗。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2290910. doi: 10.1080/14756366.2023.2290910. Epub 2023 Dec 13.
5
Virtual screening of approved clinic drugs with main protease (3CL) reveals potential inhibitory effects on SARS-CoV-2.利用主要蛋白酶（3CL）对已批准临床药物进行虚拟筛选，揭示了其对 SARS-CoV-2 的潜在抑制作用。
J Biomol Struct Dyn. 2022 Feb;40(2):685-695. doi: 10.1080/07391102.2020.1817786. Epub 2020 Sep 10.
6
Identification of polyphenols from as SARS CoV-2 main protease inhibitors using docking and molecular dynamics simulation approaches.基于对接和分子动力学模拟方法鉴定 中的多酚类化合物作为 SARS CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Oct;39(17):6747-6760. doi: 10.1080/07391102.2020.1802347. Epub 2020 Aug 7.
7
In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.通过分子对接、MMGBSA 预测结合能计算和分子动力学模拟，从计算机上鉴定潜在的关键 SARS-CoV-2 3CL 水解酶（Mpro）抑制剂。
PLoS One. 2020 Jul 24;15(7):e0235030. doi: 10.1371/journal.pone.0235030. eCollection 2020.
8
Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.通过分子对接和模拟研究鉴定 SARS-CoV-2 主要蛋白酶的潜在天然抑制剂。
J Biomol Struct Dyn. 2021 Aug;39(12):4334-4345. doi: 10.1080/07391102.2020.1776157. Epub 2020 Jun 11.
9
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.从印度香料中鉴定新型抗 nCoV 药物化合物，利用 SARS-CoV-2 主要蛋白酶作为靶点。
J Biomol Struct Dyn. 2021 Jun;39(9):3428-3434. doi: 10.1080/07391102.2020.1763202. Epub 2020 May 13.
10
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物（ Ashwagandha ）、（ Giloy ）和（ Tulsi ）的活性植物化学成分靶向 COVID-19 （ SARS-CoV-2 ）主蛋白酶 - （ Ashwagandha ）、（ Giloy ）和（ Tulsi ） - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.

引用本文的文献

1
The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation.阿魏酸衍生物对新型冠状病毒主要蛋白酶的抑制潜力：分子对接、分子动力学及药物代谢动力学/药物毒性评价
Biomedicines. 2022 Jul 25;10(8):1787. doi: 10.3390/biomedicines10081787.
2
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.SARS-CoV-2 变体的分子特征、免疫逃逸及其影响。
Signal Transduct Target Ther. 2022 Jun 28;7(1):202. doi: 10.1038/s41392-022-01039-2.

本文引用的文献

1
Omicron N501Y mutation among SARS-CoV-2 lineages: Insilico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine.新冠病毒变异株 Omicron 中的 N501Y 突变：对与酪氨酸激酶的强结合及潜在重新利用药物的计算机模拟分析。
Travel Med Infect Dis. 2022 Jan-Feb;45:102242. doi: 10.1016/j.tmaid.2021.102242. Epub 2021 Dec 17.
2
SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS.SARS-CoV-2 Nsp5 通过上调 MAVS 的 SUMOylation 激活 NF-κB 通路。
Front Immunol. 2021 Nov 10;12:750969. doi: 10.3389/fimmu.2021.750969. eCollection 2021.
3
Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L.
MG-132 对 SARS-CoV-2 主蛋白酶（Mpro/3CLpro）和人组织蛋白酶-L 的双重抑制作用的结构和生化分析。
Int J Mol Sci. 2021 Oct 29;22(21):11779. doi: 10.3390/ijms222111779.
4
Antiviral activity of silymarin and baicalein against dengue virus.水飞蓟素和黄芩素抗登革热病毒的活性。
Sci Rep. 2021 Oct 27;11(1):21221. doi: 10.1038/s41598-021-98949-y.
5
Antiviral Activity Exerted by Natural Products against Human Viruses.天然产物对人类病毒的抗病毒活性。
Viruses. 2021 May 4;13(5):828. doi: 10.3390/v13050828.
6
Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2.联合对接方法和分子动力学以鉴定针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的有效抗病毒2,5-二氨基二苯甲酮衍生物
J King Saud Univ Sci. 2021 Mar;33(2):101352. doi: 10.1016/j.jksus.2021.101352. Epub 2021 Feb 4.
7
Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study.奈非那韦立体异构体对冠状病毒主蛋白酶的影响：分子对接、分子动力学模拟及 MM/GBSA 研究。
J Mol Graph Model. 2021 Mar;103:107803. doi: 10.1016/j.jmgm.2020.107803. Epub 2020 Dec 4.
8
Drug repurposing for coronavirus (COVID-19): screening of known drugs against coronavirus 3CL hydrolase and protease enzymes.冠状病毒（COVID-19）药物再利用：针对冠状病毒 3CL 水解酶和蛋白酶的已知药物筛选。
J Biomol Struct Dyn. 2021 May;39(8):2980-2992. doi: 10.1080/07391102.2020.1758791. Epub 2020 Apr 26.
9
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.利巴韦林联合洛匹那韦/利托那韦与洛匹那韦/利托那韦单独治疗 2019 年冠状病毒病：一项回顾性队列研究。
J Infect. 2020 Jul;81(1):e1-e5. doi: 10.1016/j.jinf.2020.03.002. Epub 2020 Mar 11.
10
Antiviral Activities of Silymarin and Derivatives.水飞蓟素及其衍生物的抗病毒活性。
Molecules. 2019 Apr 19;24(8):1552. doi: 10.3390/molecules24081552.